COMMODORE CAPITAL LP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
COMMODORE CAPITAL LP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$11,483,000
-8.3%
13,049,079
+29.2%
2.43%
-13.2%
Q1 2022$12,521,000
-24.1%
10,097,229
+19.3%
2.80%
-26.8%
Q4 2021$16,507,000
+17.6%
8,464,999
+65.2%
3.82%
+3.3%
Q3 2021$14,038,000
+33.8%
5,123,509
+53.8%
3.70%
+1.2%
Q2 2021$10,494,000
+32.1%
3,331,315
-10.7%
3.66%
+15.5%
Q1 2021$7,944,000
+30.0%
3,729,694
+18.4%
3.16%
-4.7%
Q4 2020$6,111,0003,150,0003.32%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders